The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 244.00
Bid: 238.00
Ask: 250.00
Change: 0.00 (0.00%)
Spread: 12.00 (5.042%)
Open: 244.00
High: 244.00
Low: 244.00
Prev. Close: 244.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update & notice of results

11 Jul 2014 07:00

RNS Number : 0385M
Animalcare Group PLC
11 July 2014
 



 

 

Animalcare Group plc

("Animalcare" or the "Group")

 

Trading Update & Notice of Results

 

Animalcare, a leading supplier of veterinary medicines, provides the following trading update for the year ended 30th June 2014, in advance of releasing its results on Wednesday 15th October 2014.

 

Trading Update

 

The Board is very pleased with trading in the year. Revenues across the Group are up by 6.3% to approximately £12.9m (2013: £12.1m), ahead of market expectations.

 

Sales of the Licensed Veterinary Medicines product group were up by 10% versus the prior period and broadly in line with the growth seen in the wider UK licensed veterinary companion animal medicines market. The Companion Animal Identification product group has made further progress following positive results at the half-year with sales up over 8% on last year due to strong contributions from both microchip sales and database services.

 

The planned rationalisation of older, lower margin Animal Welfare products has focused the range, with revenues reducing by 4% but with gross profit growing by 8%.

 

Overall underlying operating profit is in line with market expectations and at least £2.6m for the full year. Operating cash flows reflect the planned higher inventory levels of certain commercially important products. The year end cash position remains robust at £3.8m (31st December 2013: £3.6m; 30th June 2013: £3.7m) and, alongside positive trading, gives the Board the confidence to maintain the dividend flow during the current investment cycle.

 

Summary and Outlook

 

The Board is very pleased to report the strong progress of the business versus the prior period. Revenues from key product groups, Licensed Veterinary Medicines and Companion Animal Identification, have grown well.

 

The engagement of veterinary practices and the dog-owning public in compulsory microchipping has been more measured than expected by the wider industry. However, a promotion through the calendar year to celebrate the 25th anniversary of the introduction of Animalcare's Identichip, the first microchip in the UK, has been very successful so far.

 

Emphasis on the structure and development of the sales function will further drive the business in the coming period and beyond.

 

The Board is committed to significant investment in product development which will be financed from cash generated by the business. Animalcare has recruited further staff to strengthen the product development team working on enhanced generic medicine projects. The Board believes that this investment will be key to generating continued growth in the business and further enhancing shareholder value.

 

The Board believes that the underlying business will continue to deliver growth whilst maintaining the dividend flow during the coming period of increased investment.

 

 

For further information, please contact:

 

Animalcare Group plc

Tel: 01904 487 687

Iain Menneer, Chief Executive Officer

Chris Brewster, Chief Financial Officer

Panmure Gordon (Nominated Adviser and Broker)

Nicola Marrin

Tel: 0207 886 2500

Joanne Lake/Peter Steel

Tel: 0113 357 1150

Walbrook PR Ltd

Tel: 020 7933 8780 or animalcare@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

Notes to editors

 

Animalcare is a leading veterinary sales and marketing company based in York with 57 employees including a field sales force of 15 representatives selling to all veterinary practices around the United Kingdom.

 

Animalcare has developed a range ofgeneric veterinary medicines and animal identification products primarily to companion animal veterinary markets.  

 

Animalcare operates in three product areas:

 

· Licensed Veterinary Medicines - a range of branded veterinary licensed pharmaceuticals sold to veterinary professionals in the UK and selected markets in Northern Europe. The range can be divided into four main categories; antibacterials, anaesthetics and analgesics, Aqupharm intravenous fluids and vitamins & speciality pharmaceuticals.

 

· Companion Animal Identification - Identichip is the pioneering microchip identification system in the UK. Animalcare also owns and operates the Anibase database; together the market leader in electronic identification for pets in the UK.

 

· Animal Welfare Products - a range used by veterinary professionals in the diagnosis and care of their patients, for example intravenous infusion accessories, ophthalmic instruments, hygiene solutions and bandages and dressings.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFIDDSIILIS
Date   Source Headline
30th Sep 201112:17 pmRNSTotal Voting Rights
19th Sep 20117:00 amRNSFinal Results
9th Sep 20113:09 pmRNSShare Allotment
2nd Sep 20112:45 pmRNSChange of Registered Office
1st Sep 20112:25 pmRNSShare Allotment
21st Jul 20115:12 pmRNSHolding(s) in Company
5th Jul 20117:00 amRNSTrading update
1st Jul 20113:41 pmRNSTotal Voting Rights
28th Jun 201111:33 amRNSShare Allotment/Director Shareholding
24th Jun 20117:00 amRNSAppointment of Iain Menneer
16th Jun 20119:52 amRNSHolding(s) in Company
1st Jun 201112:49 pmRNSHolding(s) in Company
31st May 201112:49 pmRNSTotal Voting Rights
25th May 20113:06 pmRNSShare Allotment & Total Voting Rights
31st Mar 20113:44 pmRNSTotal Voting Rights and Capital
18th Mar 20113:19 pmRNSIssue of Equity
18th Mar 20112:48 pmRNSHolding(s) in Company
16th Mar 201112:31 pmRNSDirector/PDMR Shareholding
17th Feb 20117:00 amRNSHalf Yearly Report
20th Jan 20117:00 amRNSPre-close trading update & Notice of results
4th Jan 20117:00 amRNSDirectorate Change
7th Dec 20101:39 pmRNSHolding(s) in Company
30th Nov 201012:03 pmRNSTotal Voting Rights
29th Nov 20105:03 pmRNSDirector/PDMR Shareholding
16th Nov 20103:41 pmRNSDirector/PDMR Shareholding
12th Nov 201012:13 pmRNSDirector/PDMR Shareholding
9th Nov 20105:05 pmRNSShare Allotment
8th Nov 20104:42 pmRNSShare Allotment
14th Oct 201010:52 amRNSDirectorate Change
4th Oct 20107:00 amRNSFinal Results
20th Sep 20107:00 amRNSDisposal
20th Sep 20107:00 amRNSDisposal of Agricultural business for ?3.25m cash
14th Sep 20107:00 amRNSPotential disposal
14th Jul 20101:41 pmRNSShare Allotment
14th Jul 201011:15 amRNSHolding(s) in Company
13th Jul 20107:00 amRNSPre-close Trading Statement
9th Jun 201011:51 amRNSHolding(s) in Company
20th Apr 20102:14 pmRNSIssue of Equity
1st Apr 20109:00 amRNSDirectorate Change
8th Mar 20107:00 amRNSDirector/PDMR Shareholding
22nd Feb 20107:30 amRNSDirectorate Change
22nd Feb 20107:00 amRNSInterim Results
14th Jan 20107:00 amRNSIssue of Equity
16th Dec 20095:43 pmRNSDirector/PDMR Shareholding
3rd Dec 200910:08 amRNSHolding(s) in Company
5th Oct 200910:54 amRNSChange of dividend record date
5th Oct 20097:00 amRNSFinal Results
20th Jul 20093:20 pmRNSDirector/PDMR Shareholding
16th Jul 20091:25 pmRNSDirector/PDMR Shareholding
8th Jul 20097:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.